Please login to the form below

Not currently logged in
Email:
Password:

Ark Therapeutics

This page shows the latest Ark Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Emas appoints Dr Neil Murray

Prior to this he was head of clinical development at Ark Therapeutics and global head of pharmacovigilance at F.Hoffmann-La Roche.

Latest news

  • MSD invests in FKD Therapies

    MSD invests in FKD Therapies. MSD has taken an equity stake in the Finland based company, FKD Therapies, owned by former CEO of Ark Therapeutics Nigel Parker. ... FKD Therapies, which has reserves of $16m, is a company started by Nigel Parker, the former

  • Ark files documentation on Cerepro

    Ark files documentation on Cerepro. Ark Therapeutics Group has requested re-examination of the marketing approval application for its brain cancer drug, Cerepro, from the EMA. ... Ark Therapeutics Group has filed documentation with the European

  • Close but no cigar

    A number of promising candidates include Introgen's contusugene ladenovec (ADVEXIN), an adenoviral p53 gene therapy, and Ark Therapeutics' sitimagene ceradenovec (Cerepro). ... Another candidate under regulatory review is sitimagene ceradenovec (Cerepro),

  • R&D news in brief

    Ark reveals new R&D head. David Eckland has been appointed head of research and development at Ark Therapeutics, the company has revealed. ... Ark Therapeutics is a spin-out biotech company from University College London and successfully floated on the

  • R&D news in brief

    to scientists working in Finland for UK biotech firm Ark Therapeutics. ... While, until now, gene therapy delivery has relied on the insertion of DNA almost at random into human chromosomes, Ark said it was using targeting molecules, known as integrase

More from news
Approximately 0 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics